» Articles » PMID: 2412669

Mechanisms of Proteoglycan Inhibition of Hydroxyapatite Growth

Overview
Specialty Pathology
Date 1985 Jul 1
PMID 2412669
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Purified bovine nasal cartilage proteoglycans (aggregate and subunit containing fractions) and to a lesser degree, chondroitin 4-sulfate of physiological size, retard seeded hydroxyapatite (HA) growth in vitro. The large hydrodynamic size and high charge density of these macromolecules are believed to be associated with the ability of proteoglycans to inhibit HA formation and growth. We now demonstrate the involvement of the negative charges of proteoglycans in this inhibition by comparing the inhibitory ability of chondroitin 4-sulfate and its desulfated analog, and by comparing the growth of HA seed crystals coated either with proteoglycan aggregates or chondroitin 4-sulfate to that of uncoated crystals. In the desulfation experiments, desulfated chondroitin sulfate was a less efficient HA growth inhibitor than untreated, undesulfated chondroitin sulfate of similar molecular size. Dextran sulfate showed higher inhibitory effectiveness than unchanged neutral dextran. Both experiments suggest that sulfate groups play an important role in the regulation of mineral deposition by proteoglycans. In the coating experiment, precoating of HA seed crystals with proteoglycan aggregates decreased the amount of HA precipitated as a function of time, suggesting proteoglycans may block the active nucleating sites on HA surface and slow down the growth process. Chondroitin 4-sulfate had a similar but weaker coating effect. Neutral dextran, having little affinity for HA, had no effect.

Citing Articles

Assessment of glycosaminoglycan content in bone using Raman spectroscopy.

Heath S, Han Y, Hua R, Roy A, Jiang J, Nyman J Bone. 2023; 171:116751.

PMID: 36996996 PMC: 10152494. DOI: 10.1016/j.bone.2023.116751.


Effect of hormone replacement therapy on bone formation quality and mineralization regulation mechanisms in early postmenopausal women.

Gamsjaeger S, Eriksen E, Paschalis E Bone Rep. 2021; 14:101055.

PMID: 33850974 PMC: 8022851. DOI: 10.1016/j.bonr.2021.101055.


Model of Pathological Collagen Mineralization Based on Spine Ligament Calcification.

Orzechowska S, Swislocka R, Lewandowski W Materials (Basel). 2020; 13(9).

PMID: 32375359 PMC: 7254246. DOI: 10.3390/ma13092130.


Phosphate regulates chondrogenesis in a biphasic and maturation-dependent manner.

Wu B, Durisin E, Decker J, Ural E, Shea L, Coleman R Differentiation. 2017; 95:54-62.

PMID: 28511052 PMC: 5528843. DOI: 10.1016/j.diff.2017.04.002.


Effects of chrondro-osseous regenerative compound associated with local treatments in the regeneration of bone defects around implants: an in vivo study.

Tonetto A, Lago P, Borba M, Rosa V Clin Oral Investig. 2015; 20(2):267-74.

PMID: 26077896 DOI: 10.1007/s00784-015-1509-1.


References
1.
Chen C, Boskey A, Rosenberg L . The inhibitory effect of cartilage proteoglycans on hydroxyapatite growth. Calcif Tissue Int. 1984; 36(3):285-90. DOI: 10.1007/BF02405332. View

2.
Maroudas A . Biophysical chemistry of cartilaginous tissues with special reference to solute and fluid transport. Biorheology. 1975; 12(3-4):233-48. DOI: 10.3233/bir-1975-123-416. View

3.
Heinonen J, Lahti R . A new and convenient colorimetric determination of inorganic orthophosphate and its application to the assay of inorganic pyrophosphatase. Anal Biochem. 1981; 113(2):313-7. DOI: 10.1016/0003-2697(81)90082-8. View

4.
Embery G, Rolla G . Interaction between sulphated macromolecules and hydroxyapatite studied by infrared spectroscopy. Acta Odontol Scand. 1980; 38(2):105-8. DOI: 10.3109/00016358009003486. View

5.
Hulth A . Experimental retardation of endochondral growth by papain. Acta Orthop Scand. 1958; 28(1):1-21. DOI: 10.3109/17453675808988604. View